openPR Logo
Press release

AIDS-related Kaposi’s Sarcoma Market Report 2017

06-19-2017 11:19 PM CET | Health & Medicine

Press release from: Transparency Market Research

AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses to cytokines, and stimulation of Kaposi’s sarcoma growth by HIV-1 trans-activating protein. It is primarily caused by weak immune system due to HIV infection. The cancer can occur on several parts of the body at the same time. It is common among HIV-positive gay or bisexual men, women who were infected with HIV through sex with bisexual men, and people from communities of Africa. It has eight times higher incidence rate in men than women. The incidence rate of AIDS-related KS has decreased over a period of time due to high awareness about sexually transmitted diseases and use of safety methods. This decrease was accelerated after the introduction of highly active antiretroviral therapy (HAART) and immunotherapies.

Get accurate market forecast and analysis on the AIDS-related Kaposi’s Sarcoma Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26111

The AIDS-related Kaposi’s sarcoma market can be segmented by type of therapy and region. Based on type of therapy, the market can be classified as HAART; local therapies such as radiation therapy, cryotherapy, laser therapy, surgical excision, topical retinoids, and intralesional vinca alkaloid therapy; immunomodulation; and cytotoxic agents such as liposomal doxorubicin (Doxil), liposomal daunorubicin (DaunoXome), Paclitaxel, and oral etoposide (VePesid). Currently, liposomal therapy has shown a significant response due to reduced cardiac toxicity and mylotoxicity, previously reported for doxorubicin and daunorubicin. Liposomal doxorubicin is considered as the first line standard for the treatment of this type of cancer. When combined with HAART, the effectiveness of liposomal doxorubicin is enhanced. Chemotherapy is a highly preferred treatment though it is costly. However, high cost of the therapy is likely to be a restraining factor in some developing and underdeveloped countries. The relation of Kaposi’s sarcoma with AIDS is projected to boost the growth of the antiretroviral therapy market. Interferon Alfa (Intron A) is a highly used drug in the class of immunotherapy agents. The demand for radiation therapy is increasing to get better physical appearance of the patient. Intralesional therapy with vinca alkaloids has limited use where localized skin lesions are observed.

The market for AIDS-related Kaposi’s sarcoma has a large opportunity for development in the near future with the discovery of novel drugs by researchers worldwide. For instance, angiogenesis plays an important role in the development of Kaposi’s sarcoma tumors. Angiogenesis inhibitors are currently being developed and are expected to be a promising therapy for the treatment of the disease in the next few years. The research undergoing at IrsiCaixa Aids Research Institute in Barcelona has increased hopes for complete removal of the virus from the blood. The medication is a combination of two HIV vaccines with anticancer drugs. Targeted therapies such as monoclonal antibodies are under clinical trials which are projected to dominate the market in the near future.

View Report @ http://www.transparencymarketresearch.com/aids-related-kaposis-sarcoma-market.html

Geographically, the global market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Among these regions, North America is dominating the market despite having lower number of incidence cases reported. This is attributed to the availability of advance therapies, high rate of diagnosis conditions, and anticipated potential to afford the high cost associated with the treatment. In Africa, the incidence of AIDS-related Kaposi’s sarcoma is significantly high. In the next few years, the market is expected to grow in Middle East & Africa owing to increased prevalence of the disease. Increasing number of regional vendor entries in the market is likely to be observed owing to patent expirations of several blockbuster drugs. Leading companies have opportunities to develop new chemotherapy agents with reduced side effects.

Key players operating in this market are Eli Lilly and Co., Bristol-Myers Squibb, Hoffmann-La Roche Inc., Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc., and GlaxoSmithKline plc

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AIDS-related Kaposi’s Sarcoma Market Report 2017 here

News-ID: 586168 • Views: 416

More Releases from Transparency Market Research

Social CRM Market to Rear Excessive Growth During 2020-2030
Social CRM Market: Introduction The social CRM market focuses on capturing the needs of consumers and generates value for them. Social customer relationship management (CRM) provides critical analysis about the market. It enables businesses to build customer relationships and improve their brand presence. The solution helps companies to monitor and analyze their reputation in the market with various keywords such as brand name and company name. Obtain Report Details @
Video Ad Insertion Platform Market: Size Industry Status Growth Opportunity For …
Video ad Insertion Platform Market – Introduction Video ad insertion platform IT enables marketers to serve different advertisements to each viewer based on consumer insights and ad campaign results. Increasing demand for OTT platforms, technological advances, and an increase in the number of internet users are all boosting the video ad insertion platform industry. Furthermore, the 6-second ad is gaining attention on various social media sites. According to new research from
Smart Luggage Market: Analysis, Strategic Assessment, Trend Outlook And Business …
Smart Luggage Market: Introduction Smart luggage are bags with remote lock systems, GPS locator, USB ports for charging the device, remote or app enabled controls, Wi-Fi or Bluetooth connectivity, and solar powered batteries. Smart luggage have anti-theft protection, which provides the user with an alarm or notification when the luggage gets disconnected or is moved out of range. Smart luggage are not only technological advanced but also have a stylish look,
Storage Resource Management Tool Market: Future Growth And Forecast With Signifi …
Global Storage Resource Management Tool Market: Introduction A storage resource management tool enables real-time and historical information for storage infrastructure with regards to capacity and performance, problem determination, device management, and configuration planning and change management. It helps the storage administrator to automate data backup, data recovery, and SAN performance analysis. The tool helps in visualizing relationships and topologies from application to storage array, analyzing health, configurations and capacity growth, and

All 5 Releases


More Releases for Kaposi’s

Kaposi's Sarcoma Treatment Market (COVID-19 Impact Analysis) 2020 Surprising Gro …
The Kaposi’s Sarcoma Treatment Market document makes businesses powerful whether it is large, medium or small for existing and succeeding in the market. The report holds a massive importance when it comes to market definition, classifications, applications and engagements. Not to mention all of the topics of this report have been thoroughly studied with the best tools and techniques. This business research report also provides CAGR value fluctuation during the
Global Kaposi’s Sarcoma Treatment Market Outlook 2020 (COVID 19 Impact Analysi …
Kaposi’s sarcoma treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. The rising prevalence of organ transplants in the markets is the factor responsible for the growth of the kaposi’s sarcoma treatment market. Get Sample Report + All Related Graphs & Charts (with COVID
Kaposi’s Sarcoma Market is Predicted to be Worth US$143.2 mn by 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of
AIDS related Kaposi’s Sarcoma Market to Witness Steady Growth During the Forec …
AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses
AIDS related Kaposi’s Sarcoma Market Projected to Grow at Steady Rate through …
AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses
New Report Examines the Growth of AIDS-related Kaposi’s Sarcoma Market Forecas …
AIDS-related Kaposi’s sarcoma is a type of cancer affecting the cells lining, the blood vessels, or lymph nodes. The cancer usually occurs as tumors on skin or mucosal surfaces. It is characterized by brown, red, or purple tumors on the affected area generally called as lesions. The major factors playing the role in the pathogenesis of the cancer are Kaposi’s sarcoma herpes virus/human herpes virus type 8 (KSHV/HHV-8), altered responses